Comprehensive Evaluation of the Bioactives of Elaeagnus umbellata for Their Antidiabetic Potential Using In Vitro and In Silico Approaches
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500610 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Mujtaba Aamir Bhat und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences and Biotechnology, Baba Ghulam Shah Badshah University, Rajouri, India. Hauptthemen laut MEDLINE: Antioxidants, Elaeagnaceae, Hypoglycemic Agents, Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
Elaeagnus umbellata is known for its medicinal properties, including its ability to promote wound healing and exhibit antidiabetic and anti‐inflammatory properties. In the present study, methanolic leaf and bark extract (MLE and MBE) of E. umbellata was tested for total phenol and flavonoid content and evaluated for antioxidant activity. FTIR and GC‐MS analysis were followed by an in silico study of bioactive constituents for their role in inhibiting advanced glycation end‐products (RAGEs) and glucagon‐like peptide‐1 (GLP1) receptors. Both extracts demonstrated significant antioxidant activity, with MLE showing stronger activity than MBE. The FTIR spectra for functional groups confirmed a diverse range of metabolites. The GC‐MS analysis showed 41 bioactive compounds exhibiting antioxidant, anti‐inflammatory, and antidiabetic activities. The docking analysis of selected compounds with RAGE and GLP1 receptors revealed variations in binding affinities, pKi values, and ligand efficiencies. E. umbellata contains a significant amount of phytochemicals exhibiting strong antioxidant activity. The activity of phenols and flavonoids suggests that they can be used as a source of natural antioxidants. Molecular docking analysis indicates that various compounds have the potential to act as effective inhibitors of RAGE and GLP, thereby modulating proinflammatory responses and mitigating oxidative damage in the cellular pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences and Biotechnology, Baba Ghulam Shah Badshah University, Rajouri, India.
- Department of Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea.
- Center for Interdisciplinary Research & Innovation, University of Kashmir, Srinagar, India.
- Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Department of Botany, Munshi Singh College, Baba Saheb Bhim Rao Ambedkar Bihar University, Muzzafarpur, India.
- Regional Research Institute of Unani Medicine, University of Kashmir, Srinagar, India.
ORCID-Profile: Arif Tasleem Jan
Zitieren
APA
Bhat, M. A., Mishra, A. K., Magray, F. A., Jan, S., Rehman, M. T., AlAjmi, M. F., Rahman, S., Wani, S. A., & Jan, A. T. (2025). Comprehensive Evaluation of the Bioactives of Elaeagnus umbellata for Their Antidiabetic Potential Using In Vitro and In Silico Approaches. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500610
Vancouver
Bhat MA, Mishra AK, Magray FA, Jan S, Rehman MT, AlAjmi MF, et al. Comprehensive Evaluation of the Bioactives of Elaeagnus umbellata for Their Antidiabetic Potential Using In Vitro and In Silico Approaches. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500610
BibTeX
@article{Bhat2025,
author = {Bhat, Mujtaba Aamir and Mishra, Awdhesh Kumar and Magray, Faizan A and Jan, Saima and Rehman, Md Tabish and AlAjmi, Mohamed F and Rahman, Safikur and Wani, Shahnawaz Ahmad and Jan, Arif Tasleem},
title = {Comprehensive Evaluation of the Bioactives of Elaeagnus umbellata for Their Antidiabetic Potential Using In Vitro and In Silico Approaches},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500610}
}
EUVIMED